Drug intelligence / Profile preview

Takeda Kampo Ichoyaku K-matsu

Development stage: Unknown
Lead developer: Takeda
Modality: Small Molecules
Administration: Oral

Overview

Takeda Kampo Ichoyaku K-matsu is a traditional Japanese Kampo herbal medicine formulated as fine granules for the treatment of gastrointestinal distress. Marketed by Alinamin Pharmaceutical (formerly Takeda Consumer Healthcare), it is based on the Koshaheiisan formulation—a blend of herbs including Atractylodes lancea rhizome, Magnolia bark, and Citrus unshiu peel—augmented with Shakuyaku (Peony root). This combination is designed to harmonize the stomach, improve digestion, and relieve pain or fullness caused by excessive food or alcohol consumption. The matsu designation indicates its powder/granule form, which is packaged in portable pouches for convenience.

Brand names: Takeda Kampo Ichoyaku K-matsu
Other names: Takeda Kampo Ichoyaku K Fine Granulesタケダ漢方胃腸薬K末

Beyond the preview

Go deeper on Takeda Kampo Ichoyaku K-matsu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Takeda Kampo Ichoyaku K-matsu.

Explore the full profile